FIGHTING CANCER BY EARLY DETECTION

WE DEVELOP, MANUFACTURE AND MARKET NON-INVASIVE
CANCER TESTS USING OUR UNIQUE TECHNOLOGY,
PARTNERING WITH LEADING CENTERS AROUND THE WORLD

Bladder EpiCheck

Reduce invasive procedures with an
accurate urine test

99.3% NPV (Ex. Ta-LG)

Bladder page

Lung EpiCheck

Detect early stage lung cancer with a
simple blood test

In development

Specificity 91%
Sensitivity 74%

Lung page

Liver EpiCheck

Early detection of liver cancer for cirrhosis
patients with a simple blood test

In development

Pan Cancer EpiCheck

Simple blood test for multiple cancer types

In development

EPICHECK IS A PLATFORM TECHNOLOGY

Combining an ultra-sensitive biochemical assay with proprietary bioinformatics and big data analysis tools

Technology page

Collaborations

We are working with leading medical centers, organizations and laboratories worldwide

  • icon

    Cleveland Clinic

  • icon

    Radboud UMC

  • icon

    Duke Hospital

  • icon

    Synlab

  • icon

    University of Washington

  • icon

    ERS

  • icon

    Vall D'Hebron

  • icon

    AMC

  • icon

    Tor Vergata

  • icon

    Hospital La Paz

  • icon

    Meir Medical Center

  • icon

    Vanderbilt University